Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV) (HD2000)

NCT00443677 Phase 3 COMPLETED

The purpose of this study is to compare the toxicities of the COPPEBVCAD vs BEACOPP vs ABVD regimens.

Details

Lead sponsor	Gruppo Italiano Studio Linfomi
Phase	Phase 3
Status	COMPLETED
Enrolment	307
Start date	2000-04
Completion	2007-06

Conditions

• Advanced Hodgkin Disease

Interventions

• COPPEBVCAD vs BEACOPP vs ABVD

Primary outcomes

• To compare the toxicity of the COPPEBVCAD vs BEACOPP vs ABVD regimens

Countries

Italy